ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CareMetx Welcomes Scott Genone as Chief Product Officer

BETHESDA, MD, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CareMetx, LLC, a leading technology-enabled Hub services company dedicated to improving patient access and adherence to specialty medications, is pleased to announce the appointment of Scott Genone as Chief Product Officer (CPO). With over 30 years of experience in healthcare technology and a proven track record in scaling product portfolios to drive meaningful patient outcomes, Genone joins CareMetx at a pivotal time for the company and the patients it serves.  

With deep expertise in product strategy, portfolio management, and the integration of innovative healthcare technologies, Genone is well-equipped to lead CareMetx in advancing its commitment to accessible, patient-centered solutions. His extensive career includes executive positions at RelayHealth and McKesson, where he drove key growth initiatives and helped lead the successful acquisition of CoverMyMeds. Through these roles, he enhanced patient affordability solutions, optimized reimbursement processes, and improved workflow efficiencies across providers, pharmacies, and pharmaceutical brands. 

“At CareMetx, we are continually innovating to serve our clients and improve patient access to life-changing medications,” said Jim Rowe, CEO of CareMetx. “Scott’s proven expertise in scaling healthcare technologies and his dedication to patient-centered care make him a natural fit for our mission. Under his leadership, CareMetx will continue to exceed expectations for our clients and the patients they support.” 

Genone joins CareMetx following his tenure as Co-Founder and CEO of TrueHLTH, a digital care navigation platform dedicated to helping patients access care, and as an advisor to private equity and healthcare technology firms. At RelayHealth, Genone was instrumental in developing groundbreaking healthcare solutions, including patient affordability and reimbursement programs that streamline workflows for providers, pharmacies, and life sciences companies. His leadership at RelayHealth drove innovative product offerings that have become essential to advancing patient access and improving outcomes across the healthcare ecosystem.

“I am thrilled to join CareMetx and contribute to developing solutions that make a tangible difference for patients,” said Genone. “Working with Jim and the CareMetx team, I look forward to creating scalable, impactful products that enhance the patient experience and drive positive health outcomes.” 

With Genone’s strategic vision and patient-focused approach, CareMetx will continue to lead the industry in delivering exceptional support to patients and clients alike.

About CareMetx  

CareMetx, LLC is a leading technology-enabled hub services company facilitating patient access and adherence to specialty medications. Serving pharmaceutical and biotechnology manufacturers, CareMetx leverages a digital front-end, proprietary automation, an integrated platform and best-in-industry call center services to promote efficiency in the healthcare ecosystem and remove barriers for patients and providers. CareMetx is committed to delivering compassionate advocacy to patients, decision-making data, and confidence-building insight to manufacturer clients. Headquartered in Bethesda, Maryland, CareMetx serves more than 80 brands. 

Learn more at https://www.caremetx.com and follow us on LinkedIn at https://www.linkedin.com/company/caremetx-llc


Julie Kaplan
CareMetx, LLC
Julie.Kaplan@caremetx.com
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.